These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 13678834)

  • 1. Mycobacterial efflux pumps and chemotherapeutic implications.
    Viveiros M; Leandro C; Amaral L
    Int J Antimicrob Agents; 2003 Sep; 22(3):274-8. PubMed ID: 13678834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mycobacterial efflux transporters in drug resistance: an unresolved question.
    De Rossi E; Aínsa JA; Riccardi G
    FEMS Microbiol Rev; 2006 Jan; 30(1):36-52. PubMed ID: 16438679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis.
    da Silva PE; Von Groll A; Martin A; Palomino JC
    FEMS Immunol Med Microbiol; 2011 Oct; 63(1):1-9. PubMed ID: 21668514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1).
    Pechalrieu D; Lopez M
    Expert Opin Ther Pat; 2015 Jun; 25(6):729-35. PubMed ID: 25752488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MmpS5/MmpL5 as an efflux pump in Mycobacterium species.
    Briffotaux J; Huang W; Wang X; Gicquel B
    Tuberculosis (Edinb); 2017 Dec; 107():13-19. PubMed ID: 29050760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of fluoroquinolone resistance in Mycobacterium tuberculosis.
    Zhang YJ; Li XJ; Mi KX
    Yi Chuan; 2016 Oct; 38(10):918-927. PubMed ID: 27806933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The internal gene duplication and interrupted coding sequences in the MmpL genes of Mycobacterium tuberculosis: Towards understanding the multidrug transport in an evolutionary perspective.
    Sandhu P; Akhter Y
    Int J Med Microbiol; 2015 May; 305(3):413-23. PubMed ID: 25841626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex.
    Rodrigues L; Machado D; Couto I; Amaral L; Viveiros M
    Infect Genet Evol; 2012 Jun; 12(4):695-700. PubMed ID: 21871582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soybean lectin induces autophagy through P2RX7 dependent activation of NF-κB-ROS pathway to kill intracellular mycobacteria.
    Mishra A; Behura A; Kumar A; Ghosh A; Naik L; Mawatwal S; Mohanty SS; Mishra A; Saha S; Bhutia SK; Singh R; Dhiman R
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129806. PubMed ID: 33253803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Old and new anti-mycobacterial drugs. Fatty acid synthesis as a target].
    Topf CM; Schiebel J; Kisker C; Holzgrabe U
    Pharm Unserer Zeit; 2012 Jan; 41(1):64-70. PubMed ID: 22470920
    [No Abstract]   [Full Text] [Related]  

  • 11. Altered drug efflux under iron deprivation unveils abrogated MmpL3 driven mycolic acid transport and fluidity in mycobacteria.
    Pal R; Hameed S; Fatima Z
    Biometals; 2019 Feb; 32(1):49-63. PubMed ID: 30430296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring efflux and permeability in mycobacteria.
    Rodrigues L; Viveiros M; Aínsa JA
    Methods Mol Biol; 2015; 1285():227-39. PubMed ID: 25779319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
    Zanetti S; Sechi LA; Molicotti P; Cannas S; Bua A; Deriu A; Carta A; Paglietti G
    Int J Antimicrob Agents; 2005 Feb; 25(2):179-81. PubMed ID: 15664491
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.
    Amaral L; Martins M; Viveiros M
    J Antimicrob Chemother; 2007 Jun; 59(6):1237-46. PubMed ID: 17218448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why thioridazine in combination with antibiotics cures extensively drug-resistant Mycobacterium tuberculosis infections.
    Amaral L; Viveiros M
    Int J Antimicrob Agents; 2012 May; 39(5):376-80. PubMed ID: 22445204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A resistant organism fight with modern weapons. Biology of mycobacteria and new molecular targets].
    Koch O; Selzer PM
    Pharm Unserer Zeit; 2012 Jan; 41(1):19-26. PubMed ID: 22470915
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of efflux pump inhibitors in antituberculosis therapy.
    Song L; Wu X
    Int J Antimicrob Agents; 2016 Jun; 47(6):421-9. PubMed ID: 27211826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, identification and drug sensitivity pattern of mycobacterial strains isolated from human patients.
    Nain PS; Chandiramani NK; Darg DN
    Indian J Pathol Microbiol; 1987 Jul; 30(3):261-6. PubMed ID: 3130312
    [No Abstract]   [Full Text] [Related]  

  • 19. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
    Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
    Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
    Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
    Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.